Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8474077 | Journal of Molecular and Cellular Cardiology | 2015 | 11 Pages |
Abstract
Abdominal Aortic Aneurysm (AAA) is a major cause of mortality and morbidity in men over 65Â years of age. Male apolipoprotein E knockout (ApoEâ/â) mice infused with angiotensin II (AngII) develop AAA. Although AngII stimulates both JAK/STAT and Toll-like receptor 4 (TLR4) signaling pathways, their involvement in AngII mediated AAA formation is unclear. Here we used the small molecule STAT3 inhibitor, S3I-201, the TLR4 inhibitor Eritoran and ApoEâ/âTLR4â/â mice to evaluate the interaction between STAT3 and TLR4 signaling in AngII-induced AAA formation. ApoEâ/â mice infused for 28Â days with AngII developed AAAs and increased STAT3 activation and TLR4 expression. Moreover, AngII increased macrophage infiltration and the ratio of M1 (pro-inflammatory)/M2 (healing) macrophages in aneurysmal tissue as early as 7-10Â days after AngII infusion. STAT3 inhibition with S3I-201 decreased the incidence and severity of AngII-induced AAA formation and decreased MMP activity and the ratio of M1/M2 macrophages. Furthermore, AngII-mediated AAA formation, MMP secretion, STAT3 phosphorylation and the ratio of M1/M2 macrophages were markedly decreased in ApoEâ/âTLR4â/â mice, and in Eritoran-treated ApoEâ/â mice. TLR4 and pSTAT3 levels were also increased in human aneurysmal tissue. These data support a role of pSTAT3 in TLR4 dependent AAA formation and possible therapeutic roles for TLR4 and/or STAT3 inhibition in AAA.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cell Biology
Authors
Zhexue Qin, Jessamyn Bagley, Galina Sukhova, Wendy E. Baur, Ho-Jin Park, Debbie Beasley, Peter Libby, Yali Zhang, Jonas B. Galper,